KDNY
Swiss National Bank’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-100,300
| Closed | -$3.85M | – | 2637 |
|
|
2023
Q2 | $3.85M | Buy |
100,300
+10,600
| +12% | +$407K | ﹤0.01% | 1466 |
|
|
2023
Q1 | $2.08M | Sell |
89,700
-9,000
| -9% | -$208K | ﹤0.01% | 1820 |
|
|
2022
Q4 | $2.59M | Buy |
98,700
+5,200
| +6% | +$136K | ﹤0.01% | 1739 |
|
|
2022
Q3 | $1.84M | Hold |
93,500
| – | – | ﹤0.01% | 1931 |
|
|
2022
Q2 | $1.64M | Buy |
+93,500
| New | +$1.64M | ﹤0.01% | 2059 |
|
|
2019
Q4 | – | Sell |
-89,000
| Closed | -$94K | – | 2549 |
|
|
2019
Q3 | $94K | Hold |
89,000
| – | – | ﹤0.01% | 2518 |
|
|
2019
Q2 | $137K | Buy |
89,000
+15,700
| +21% | +$24.2K | ﹤0.01% | 2553 |
|
|
2019
Q1 | $292K | Hold |
73,300
| – | – | ﹤0.01% | 2464 |
|
|
2018
Q4 | $194K | Hold |
73,300
| – | – | ﹤0.01% | 2518 |
|
|
2018
Q3 | $539K | Hold |
73,300
| – | – | ﹤0.01% | 2391 |
|
|
2018
Q2 | $513K | Buy |
73,300
+15,800
| +27% | +$111K | ﹤0.01% | 2434 |
|
|
2018
Q1 | $535K | Buy |
57,500
+7,200
| +14% | +$67K | ﹤0.01% | 2353 |
|
|
2017
Q4 | $377K | Hold |
50,300
| – | – | ﹤0.01% | 2463 |
|
|
2017
Q3 | $536K | Hold |
50,300
| – | – | ﹤0.01% | 2358 |
|
|
2017
Q2 | $573K | Buy |
50,300
+11,800
| +31% | +$134K | ﹤0.01% | 2364 |
|
|
2017
Q1 | $414K | Hold |
38,500
| – | – | ﹤0.01% | 2425 |
|
|
2016
Q4 | $439K | Hold |
38,500
| – | – | ﹤0.01% | 2434 |
|
|
2016
Q3 | $479K | Hold |
38,500
| – | – | ﹤0.01% | 2370 |
|
|
2016
Q2 | $435K | Hold |
38,500
| – | – | ﹤0.01% | 2420 |
|
|
2016
Q1 | $477K | Buy |
38,500
+6,700
| +21% | +$83K | ﹤0.01% | 2331 |
|
|
2015
Q4 | $895K | Buy |
+31,800
| New | +$895K | ﹤0.01% | 1900 |
|